A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke–Spiegler syndrome
Open Access
- 1 October 2012
- journal article
- letter
- Published by Wiley in Experimental Dermatology
- Vol. 21 (12), 967-969
- https://doi.org/10.1111/exd.12040
Abstract
Brooke–Spiegler syndrome (BSS; OMIM 605041) is an autosomal dominant disease characterized by skin appendage tumors due to mutations in the cylindromatosis gene (CYLD). We investigated a Hungarian BSS pedigree with two affected members, father and daughter. Direct sequencing demonstrated a novel missense mutation (c.2613C>G; p.His871Gln) in exon 19 within the ubiquitin-specific protease domain of the encoded protein. We performed preliminary analysis to reveal the functional role of this novel mutation. Our data suggest that this novel CYLD mutation leads to increased ubiquitination of NEMO through influencing deubiquitinating activity of the CYLD protein and thus may result in enhanced NF-κB signalling.Keywords
This publication has 26 references indexed in Scilit:
- The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor β (TGF-β) Signaling and the Development of Regulatory T CellsJournal of Biological Chemistry, 2011
- Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populationsEuropean Journal of Immunology, 2011
- Recurrent CYLD Nonsense Mutation Associated With a Severe, Disfiguring Phenotype in an African American Family With Multiple Familial TrichoepitheliomaThe American Journal of Dermatopathology, 2011
- Identification of a large rearrangement in CYLD as a cause of familial cylindromatosisFamilial Cancer, 2010
- CARMA1 Regulation of Regulatory T Cell Development Involves Modulation of Interleukin-2 Receptor SignalingJournal of Biological Chemistry, 2010
- Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signalingHuman Mutation, 2009
- Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasomeThe EMBO Journal, 2009
- Deubiquitination of Lys63-Linkage by a CYLD UBPStructure, 2008
- Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD The Journal of Experimental Medicine, 2007
- Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responsesThe Journal of Experimental Medicine, 2007